Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

The closing of the private placement is expected to occur on or about January 2, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the ...

Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins

Syrma Johari’s leadership shared a similar sentiment, noting that the partnership reflects a strong alignment in innovation, quality, and long-term vision, and that it is pleased to support INBS in ...
PlasticsToday

Intelligent Bio Solutions Partners With Syrma Johari MedTech As It Prepares to Enter US Market

The collaboration will enable Intelligent Bio Solutions to scale production of its breakthrough drug-screening device to meet ...
Investing.com South Africa

Intelligent Bio Solutions stock falls after $10 million private placement

Investing.com -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock fell 21.3% in after-hours trading Wednesday following the company’s announcement of a $10 million private placement with two ...
Seeking Alpha

Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants

NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time ...
Nasdaq

Intelligent Bio Solutions Inc. Reports 32.6% Surge in Gross Profit Amid Strategic Growth Initiatives

Intelligent Bio Solutions forecasts a 32.6% profit increase, driven by higher-margin cartridge sales and market expansion efforts. Intelligent Bio Solutions Inc. announced preliminary unaudited ...
Seeking Alpha

Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering

NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time ...
WGNO

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
The National Law Review

Intelligent Bio Solutions Inc. Announces Reverse Stock Split

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...
Nasdaq

Intelligent Bio Solutions Inc. Reports Significant Growth Across Global Operations with Over 450 Active Accounts and Expansion into New Sectors

Intelligent Bio Solutions Inc. reports significant account growth and expansion in new sectors, enhancing its drug screening technology's global presence. Intelligent Bio Solutions Inc. (INBS), a ...
The National Law Review

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares ...

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, ...